Stocks making the biggest moves premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt & more

Premarket movers were led by UnitedHealth (+7%+) after Q2 adjusted EPS of $6.38 beat estimates ($4.90) and the company raised full-year outlook, while TSMC (-4%) reported an earnings beat but lifted capex guidance to $60B–$64B (from $52B–$56B) and added $100B in Arizona. AtaiBeckley surged (+34.5%) on Eli Lilly’s $2.8B acquisition offer (~$6.75/share, +26% vs. close), with potential upside of up to $2.50/share on milestones. Offsetting losers included GE Aerospace (-4%) and United Airlines (-3%+) as both raised guidance but faced stock declines tied to relative reaction to results and softer Q3 outlook (United: $2.50–$3.50 vs. $3.53 expected) plus $6B in added fuel costs.

Analysis

TSM’s capex step-up is the cleaner signal than the earnings beat: it shifts value from near-term free cash flow to the ecosystem that sells picks-and-shovels into AI/foundry buildouts. That is supportive for ASML, AMAT, LRCX and KLAC over the next 3-12 months, while TSM likely trades with a margin/FCF discount until the market can quantify depreciation and execution risk from the Arizona expansion. The contrarian point is that if customers are still demanding more capacity, this is not a demand problem — it is a spending-mix problem — so any TSM pullback can reverse quickly if management frames the spend as pre-sold rather than speculative.

UNH looks like a cost-trend signal more than a one-quarter beat: if this is real, managed care has pricing power, but the second-order loser is the hospital/provider group if reimbursement pressure intensifies and utilization remains disciplined. I would treat the move as supportive for ELV/HUM only if subsequent claims data confirm lower medical cost ratios; otherwise it is vulnerable to being faded once the market recognizes it may be reserve timing or a favorable mix effect. GE Aerospace’s selloff despite raised outlook suggests the market is already discounting quality compounders unless order conversion and aftermarket growth accelerate.

UAL is the clearest near-term short because fuel is a blunt margin headwind that cannot be hedged away fast enough if the price trend persists; the risk window is 1-2 quarters, not years. JBHT is the better read-through on freight: improving intermodal demand argues against a broad industrial slowdown and is constructive for rail volume and select trucking names, but not enough to declare a durable cycle turn. The consensus may be overreacting to airline weakness while underappreciating that freight stabilization usually shows up earlier in asset-light logistics than in passenger airlines.

Key Decisions for Investors

• Long AMAT/LRCX vs short TSM for 1-3 months; thesis: capex reallocation benefits semi-equipment more than foundry margins. Risk/reward is roughly 2:1 if semicap multiples re-rate on order growth; exit if TSM gross margin/FCF guidance is unaffected by the capex increase.
• Buy UNH on any post-gap consolidation, or express via long UNH / short HCA into the next managed-care print; thesis: cost discipline should support insurer margins more than provider reimbursement. Falsifier: any upward revision in medical cost trend or weaker 2H membership/guidance.
• Short UAL outright or via 1-2 month puts on any bounce; thesis: fuel-cost guidance is the fastest path to estimate downgrades across airlines. Falsifier: a sharp drop in jet fuel/Brent or evidence of fare increases holding despite softer guidance.
• Watch JBHT as a tactical long on confirmation, not chase; if intermodal strength persists, add versus a cyclical freight basket (rail/trucking proxies). Falsifier: if next monthly freight data roll over, treat as a one-quarter anomaly.
• No aggressive trade in GE Aerospace until orders/book-to-bill confirm. The stock is telling us the market wants evidence of incremental demand, not just an earnings beat.